| BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma P Bandopadhayay, G Bergthold, B Nguyen, S Schubert, S Gholamin, ... Clinical Cancer Research 20 (4), 912-925, 2014 | 400 | 2014 |
| HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma Y Pei, KW Liu, J Wang, A Garancher, R Tao, LA Esparza, DL Maier, ... Cancer cell 29 (3), 311-323, 2016 | 268 | 2016 |
| A hematogenous route for medulloblastoma leptomeningeal metastases L Garzia, N Kijima, AS Morrissy, P De Antonellis, A Guerreiro-Stucklin, ... Cell 172 (5), 1050-1062. e14, 2018 | 143 | 2018 |
| Activation of Rac1 by Src-dependent phosphorylation of Dock180Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans H Feng, B Hu, KW Liu, Y Li, X Lu, T Cheng, JJ Yiin, S Lu, S Keezer, ... The Journal of clinical investigation 121 (12), 4670-4684, 2011 | 134 | 2011 |
| Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity JJ Yiin, B Hu, MJ Jarzynka, H Feng, KW Liu, JY Wu, HI Ma, SY Cheng Neuro-oncology 11 (6), 779-789, 2009 | 119 | 2009 |
| SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans KW Liu, H Feng, R Bachoo, A Kazlauskas, EM Smith, K Symes, ... The Journal of clinical investigation 121 (3), 905-917, 2011 | 109 | 2011 |
| Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion H Feng, KW Liu, P Guo, P Zhang, T Cheng, MA McNiven, GR Johnson, ... Oncogene 31 (21), 2691-2702, 2012 | 84 | 2012 |
| Molecular mechanisms and therapeutic targets in pediatric brain tumors KW Liu, KW Pajtler, BC Worst, SM Pfister, RJ Wechsler-Reya Science signaling 10 (470), eaaf7593, 2017 | 73 | 2017 |
| Platelet-derived growth factor receptor alpha in glioma: a bad seed KW Liu, B Hu, SY Cheng Chinese journal of cancer 30 (9), 590, 2011 | 56 | 2011 |
| Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ... Nature communications 9 (1), 4121, 2018 | 50 | 2018 |
| ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain JJ Yiin, B Hu, PA Schornack, RS Sengar, K Liu, H Feng, FS Lieberman, ... Molecular cancer therapeutics 9 (4), 929-941, 2010 | 41 | 2010 |
| Platelet-derived growth factor signaling in human malignancies KW Liu, B Hu, SY Cheng Chinese journal of cancer 30 (9), 581, 2011 | 30 | 2011 |
| Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma J Wang, DM Merino, N Light, BL Murphy, YD Wang, X Guo, AP Hodges, ... Cancer research 79 (9), 2208-2219, 2019 | 23 | 2019 |
| High-throughput drug screening identifies Hdac inhibitors as candidate therapeutics for Myc-driven Medulloblastoma RJ Wechsler-Reya, Y Pei, KW Liu, J Wang, LA Esparza, DL Maier, XN Li, ... Neuro-oncology 16 (Suppl 3), iii29, 2014 | 1 | 2014 |
| NEURO-ONCOLOGY FM MBL Neuro-Oncology 16, i71-i96, 2014 | 1 | 2014 |
| Supplemental information for H Feng, KW Liu, P Guo, P Zhang, T Cheng, MA McNiven, GR Johnson, ... Aerosol Science and Technology, 2017 | | 2017 |
| PTPS-17LEPTOMENINGEAL METASTASIS IN MYC-DRIVEN MEDULLOBLASTOMA KW Liu, V Ramaswamy, M Taylor, R Wechsler-Reya Neuro-oncology 17 (Suppl 5), v182, 2015 | | 2015 |
| MB-13HDAC AND PI3K ANTAGONISTS COOPERATE TO INHIBIT GROWTH OF MYC-DRIVEN MEDULLOBLASTOMA KW Liu, Y Pei, R Wechsler-Reya Neuro-Oncology 17 (Suppl 3), iii22, 2015 | | 2015 |
| HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA KW Liu, Y Pei, R Wechsler-Reya NEURO-ONCOLOGY 16, 81-81, 2014 | | 2014 |
| Medulloblastoma models which harbor amplifications of myc family members are sensitive to BET-Bromodomain inhibition P Bandopadhayay, G Bergthold, B Nguyen, S Schubert, S Gholamin, ... Neuro-Oncology 16, 90-90, 2014 | | 2014 |
